Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Connective and Soft Tissue”

3,807 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,807 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Early research (Phase 1)Looking for participantsNCT06083883
What this trial is testing

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

Who this might be right for
Synovial SarcomaMyxoid/Round Cell Liposarcoma
M.D. Anderson Cancer Center 44
Not applicableStudy completedNCT00020527
What this trial is testing

Caspofungin Acetate in Treating Children With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionKidney Cancer+5 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT02606461
What this trial is testing

Selinexor in Advanced Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
Karyopharm Therapeutics Inc 342
Testing effectiveness (Phase 2)Study completedNCT00001566
What this trial is testing

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Who this might be right for
Ewing's SarcomaRhabdomyosarcoma
National Cancer Institute (NCI) 42
Not applicableActive Not RecruitingNCT07465822
What this trial is testing

The Learning Curve of a Gynecology and Obstetrics Resident Performing Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) Hysterectomy in a University Hospital

Who this might be right for
Abnormal Uterine Bleeding, UnspecifiedBenign Gynecological DiseaseAdenomyosis of Uterus+1 more
Cukurova University 19
Testing effectiveness (Phase 2)Study completedNCT04633122
What this trial is testing

Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumor(GIST)
Zai Lab (Shanghai) Co., Ltd. 108
Testing effectiveness (Phase 2)Ended earlyNCT00880542
What this trial is testing

Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery

Who this might be right for
Sarcoma
Jonsson Comprehensive Cancer Center 7
Not applicableStudy completedNCT06248866
What this trial is testing

Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis: A Randomized Controlled Trial

Who this might be right for
Palmar Fibromatosis
Cairo University 60
Not applicableUnknownNCT04164953
What this trial is testing

Tolerance and Efficacy Study of Second-line Surgery After Percutaneous Needle Aponeurotomy for Dupuytren's Disease.

Who this might be right for
Dupuytren's DiseaseSurgical Incision
GCS Ramsay Santé pour l'Enseignement et la Recherche 50
Testing effectiveness (Phase 2)Study completedNCT01755195
What this trial is testing

Cabozantinib for Adults With Advanced Soft Tissue Sarcoma

Who this might be right for
Refractory Soft Tissue Sarcomas
National Cancer Institute (NCI) 55
Not applicableActive Not RecruitingNCT06737172
What this trial is testing

Functional and Structural Outcomes Following Childhood Bone or Soft Tissue Sarcomas of the Lower Extremity

Who this might be right for
Soft Tissue Sarcoma of the Lower ExtremityBone Sarcoma of the Lower ExtremityChildhood and Adolescent Cancer
Technical University of Munich 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817095
What this trial is testing

SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Undifferentiated Pleomorphic Sarcoma (UPS)
Tianjin Medical University Cancer Institute and Hospital 39
Not applicableStudy completedNCT03130751
What this trial is testing

Mobile Self Management and Support for Adolescents and Young Adults With Cancer

Who this might be right for
Sarcoma
University of California, Los Angeles 20
Not applicableStudy completedNCT05925153
What this trial is testing

Vision Screening Study for College Students at Nankai University

Who this might be right for
Myoma
Tianjin Eye Hospital 8,500
Post-approval studies (Phase 4)UnknownNCT00777504
What this trial is testing

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Who this might be right for
Renal Cell CarcinomaGastrointestinal Stromal Tumor
Radboud University Medical Center 30
Large-scale testing (Phase 3)Study completedNCT02672527
What this trial is testing

Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Gustave Roussy, Cancer Campus, Grand Paris 103
Early research (Phase 1)Ended earlyNCT05609942
What this trial is testing

Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies

Who this might be right for
Advanced Systemic Mastocytosis
Blueprint Medicines Corporation 9
Early research (Phase 1)Study completedNCT00603356
What this trial is testing

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Not applicableUnknownNCT00264056
What this trial is testing

Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases

Who this might be right for
Advanced Metastastic Malignant MelanomaRefractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Fachklinik Hornheide an der Universität Münster 26
Next Page